Gamoran & Doron 2023 OCD.app Real-World Study Summary

Plain-English summary of the 2023 OCD.app real-world study, including 46,955 users, OCI-R outcomes, and clinically significant improvement.

This page is a supporting reference summary. For visitor-facing interpretation and next steps, use the related OCD condition case study.

2023year
OCDcondition
Gamoranlead author
DOIsource linked

Paper summary

OCD.app Real-World Study

This real-world observational study analyzed OCD.app usage from October 2020 to June 2022, including 46,955 baseline users, 13,568 users at the payment barrier, and 1,732 users at the final level.

Main finding

What this paper contributes.

The study reported medium effect-size reductions in OCD symptoms, with stronger effects among users who started with severe OCD symptoms. It also reported that 16% of users with severe symptoms achieved clinically significant improvement on the OCI-R threshold used in the study.

Why it matters

Supports the OCD evidence page.

Real-world observational usage data rather than a small lab-only sample.
OCI-R used as the OCD symptom measure.
Best used as the headline evidence page for ocd.app symptom reduction.
Related condition page

OCD case study

The condition page translates this paper alongside related studies and keeps the user-facing SEO target focused on the condition rather than the paper title.

How this page fits

Reference detail with broader context nearby.

This page keeps the paper-specific details in one place. The related condition page explains how the study fits into the broader evidence for OCD support.


Take The First Step To
Better Mental Health

Download ocd.app and take your first OCI-4 assessment. Join our community of 150,000+ people on the path to recovery.

Get the App Free →